Invention Grant
US07790751B2 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
失效
氮茚基-3-磺基吲唑衍生物作为5-羟基色胺-6配体
- Patent Title: Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
- Patent Title (中): 氮茚基-3-磺基吲唑衍生物作为5-羟基色胺-6配体
-
Application No.: US11504243Application Date: 2006-08-14
-
Publication No.: US07790751B2Publication Date: 2010-09-07
- Inventor: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Kevin Liu , Geraldine Ruth McFarlane , Cristina Grosanu , Jennifer Rebecca Lo , Albert Jean Robichaud
- Applicant: Hassan Mahmoud Elokdah , Alexander Alexei Greenfield , Kevin Liu , Geraldine Ruth McFarlane , Cristina Grosanu , Jennifer Rebecca Lo , Albert Jean Robichaud
- Applicant Address: US NY New York
- Assignee: Wyeth LLC
- Current Assignee: Wyeth LLC
- Current Assignee Address: US NY New York
- Agent Jennifer A. Kispert; Garth C. Butterfield
- Main IPC: A61K31/454
- IPC: A61K31/454 ; C07D403/02

Abstract:
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
Public/Granted literature
- US20070054896A1 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands Public/Granted day:2007-03-08
Information query
IPC分类: